Use of botulinum toxin type A to prevent widening of facial scars [2]

Plastic and Reconstructive Surgery

Volumn 119, Issue 1, 2007, Pages 423-424

  Venus, Matthew R ^a  

^a GEORGE ELIOT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BOTULINUM TOXIN A; CONTRACTUBEX; NEUROTOXIN; MUSCLE RELAXANT AGENT;

CHILD HEALTH CARE; CLINICAL PROTOCOL; DISEASE EXACERBATION; DRUG USE; FACE; HUMAN; HYPERTROPHIC SCAR; LETTER; PRIORITY JOURNAL; SCAR; SCAR FORMATION; WOUND HEALING; NOTE; SKIN DISEASE;

BOTULINUM TOXIN TYPE A; CICATRIX; FACIAL DERMATOSES; HUMANS; NEUROMUSCULAR AGENTS;

EID: 33847032211     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000245337.38327.80     Document Type: Letter

References (2)

1. Wilson, A. M. Use of botulinum toxin type A to prevent widening of facial scars. Plast. Reconstr. Surg. 117: 1758, 2006.
2. Holger, G., Gassner, M. D., Sherris, D. A., and Otley, C. C. Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast. Reconstr. Surg. 105: 1948, 2000.